Half-year report · HY
6062.TEDINET S100XJIE
Period2025-07-01 → 2025-12-31
Filed2026-02-05
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥22.3bn | 2025-07-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥46.7bn | 2024-07-01 → 2025-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥20.1bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Operating income | ¥2.4bn | 2025-07-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥1.8bn | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥2.5bn | 2025-07-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥4.0bn | 2024-07-01 → 2025-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.9bn | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.5bn | 2025-07-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.9bn | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.6bn | 2025-07-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.9bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.3bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.6bn | 2025-07-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | ¥1.3bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥53.2bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥52.4bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥53.0bn | at 2024-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥31.8bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥31.7bn | at 2025-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥21.4bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥20.7bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥19.0bn | at 2024-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.6bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.1bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥7.6bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.1bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.3bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.6bn | at 2024-06-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.4bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.7bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥2.0bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.2bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥8.5bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.4bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.7bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.3bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.0bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥50.41 | 2025-07-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥89.89 | 2024-07-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.93 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥50.34 | 2025-07-01 → 2025-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥89.77 | 2024-07-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥38.88 | 2024-07-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 40.1% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.4% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.8% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2025-07-01 → 2025-12-31 | ¥1.3bn |
| Otherother segments | revenue external | 2025-07-01 → 2025-12-31 | ¥990m |
| Otherother segments | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥324m |
| Otherother segments | segment profit | 2025-07-01 → 2025-12-31 | ¥23m |
| Reconciling Itemsreconciling | revenue | 2025-07-01 → 2025-12-31 | −¥324m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-07-01 → 2025-12-31 | −¥324m |
| Reconciling Itemsreconciling | segment profit | 2025-07-01 → 2025-12-31 | −¥617m |
| Nursing Carereportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥21.3bn |
| Nursing Carereportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥21.3bn |
| Nursing Carereportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥3.0bn |
| —segment total | revenue | 2025-07-01 → 2025-12-31 | ¥22.7bn |
| —segment total | revenue external | 2025-07-01 → 2025-12-31 | ¥22.3bn |
| —segment total | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥324m |
| —segment total | segment profit | 2025-07-01 → 2025-12-31 | ¥3.0bn |
| Otherother segments | revenue | 2024-07-01 → 2024-12-31 | ¥1.4bn |
| Otherother segments | revenue external | 2024-07-01 → 2024-12-31 | ¥1.1bn |
| Otherother segments | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥302m |
| Otherother segments | segment profit | 2024-07-01 → 2024-12-31 | −¥1m |
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥302m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥302m |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥623m |
| Nursing Carereportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥18.9bn |
| Nursing Carereportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥18.9bn |
| Nursing Carereportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥2.4bn |
| —segment total | revenue | 2024-07-01 → 2024-12-31 | ¥20.4bn |
| —segment total | revenue external | 2024-07-01 → 2024-12-31 | ¥20.1bn |
| —segment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥302m |
| —segment total | segment profit | 2024-07-01 → 2024-12-31 | ¥2.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 491
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of investment securities inv cf | Prior1InterimDuration | -2056000000 | JPY |
| Purchase of investment securities inv cf | InterimDuration | － | JPY |
| Decrease increase in money held in trust inv cf | Prior1InterimDuration | -667000000 | JPY |
| Decrease increase in money held in trust inv cf | InterimDuration | -44000000 | JPY |
| Payments for guarantee deposits inv cf | Prior1InterimDuration | -511000000 | JPY |
| Payments for guarantee deposits inv cf | InterimDuration | -97000000 | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1InterimDuration | -558000000 | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | InterimDuration | － | JPY |
| Other net inv cf | Prior1InterimDuration | 8000000 | JPY |
| Other net inv cf | InterimDuration | 11000000 | JPY |
| Net cash provided by used in investment activities | Prior1InterimDuration | -6353000000 | JPY |
| Net cash provided by used in investment activities | InterimDuration | -2175000000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1InterimDuration | 1693000000 | JPY |
| Net increase decrease in short term loans payable fin cf | InterimDuration | 19000000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1InterimDuration | 2874000000 | JPY |
| Proceeds from long term loans payable fin cf | InterimDuration | － | JPY |
| Repayment of long term loans payable fin cf | Prior1InterimDuration | -526000000 | JPY |
| Repayment of long term loans payable fin cf | InterimDuration | -563000000 | JPY |
| Repayments of lease obligations fin cf | Prior1InterimDuration | -57000000 | JPY |
| Repayments of lease obligations fin cf | InterimDuration | -61000000 | JPY |
| Cash dividends paid fin cf | Prior1InterimDuration | -979000000 | JPY |
| Cash dividends paid fin cf | InterimDuration | -1110000000 | JPY |
| Other net fin cf | Prior1InterimDuration | -0 | JPY |
| Other net fin cf | InterimDuration | － | JPY |
| Net cash provided by used in financing activities | Prior1InterimDuration | 3005000000 | JPY |
| Net cash provided by used in financing activities | InterimDuration | -1715000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1InterimDuration | -5348000000 | JPY |
| Net increase decrease in cash and cash equivalents | InterimDuration | -1520000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 12640000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 9149000000 | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | Prior1InterimDuration | 5000000 | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | InterimDuration | － | JPY |
| Cash and cash equivalents | Prior1InterimInstant | 7296000000 | JPY |
| Cash and cash equivalents | InterimInstant | 7629000000 | JPY |
| Retirement benefit expenses sga | Prior1InterimDuration | 12000000 | JPY |
| Retirement benefit expenses sga | InterimDuration | 11000000 | JPY |
| Provision for bonuses sga | Prior1InterimDuration | 8000000 | JPY |
| Provision for bonuses sga | InterimDuration | 8000000 | JPY |
| Taxes and dues sga | Prior1InterimDuration | 493000000 | JPY |
| Taxes and dues sga | InterimDuration | 487000000 | JPY |
| Commission fee sga | Prior1InterimDuration | 422000000 | JPY |
| Commission fee sga | InterimDuration | 380000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E26444-000NursingCareReportableSegmentsMember | 18944000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_OtherReportableSegmentsMember | 1107000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReportableSegmentsMember | 20051000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1InterimDuration | 20051000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E26444-000NursingCareReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_OtherReportableSegmentsMember | 302000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_ReportableSegmentsMember | 302000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |